Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

MDGL vs SMMT: stock comparison and AI forecast

Madrigal Pharmaceuticals, Inc. (MDGL) and Summit Therapeutics Inc. (SMMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

MDGL Madrigal Pharmaceuticals, Inc.

Market Cap
$9.96B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

SMMT Summit Therapeutics Inc.

Market Cap
$11.81B
P/E Ratio
–
Size
large-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

MDGL · SMMT

Key facts

  • SMMT is 1.2 times larger than MDGL by market capitalization ($11.81B against $9.96B).
  • MDGL carries 1.38 times debt per unit of equity, against 0.19 times for SMMT.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricMDGLSMMT
Market Cap$9.96B$11.81B
P/B Ratio19.02x18.74x
EPS$-12.87$-0.96
Book Value/Share$22.67$0.79
Revenue/Share$61.51–
FCF/Share$-8.93$-0.58

Profitability & Margins

MetricMDGLSMMT
ROE-62.1%-135.9%
ROA-26.1%-113.8%
ROIC-37.1%–
Operating Margin-22.7%–
Net Margin-22.9%–
EBT Margin-21.9%–
Tax Rate–0.0%

Financial Health

MetricMDGLSMMT
Current Ratio3.20x6.96x
Quick Ratio2.94x–
D/E Ratio1.38x0.19x
Financial Leverage2.38x1.19x
Interest Coverage-24.1x-512.6x
Working Capital$825M$617M

Cash Flow

MetricMDGLSMMT
Operating Cash Flow-$198M-$458M
Free Cash Flow-$206M-$460M
Capital Spending-$9M-$1M
FCF/Sales-14.5%–
CapEx/Sales0.6%–

Operational Efficiency

MetricMDGLSMMT
Asset Turnover1.14x–
Receivables Turnover7.4x–
Fixed Assets Turnover122.6x–
Days Sales Outstanding49 days–

Income Statement

MetricMDGLSMMT
Total Revenue$1.42B–
Operating Income-$323M–
Net Income-$325M-$856M
R&D Expense$490M$569M
SG&A Expense$1.01B–

Dividend & Shareholder Information

MetricMDGLSMMT
Shares Outstanding23M798M
FAQ

MDGL vs SMMT: stock comparison and AI forecast

Which is bigger, MDGL or SMMT?

SMMT is 1.2 times larger than MDGL by market capitalization ($11.81B against $9.96B).

Which one does Intratio's AI model rank higher, MDGL or SMMT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.